The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus
Abstract
Summary: Aims Recent studies have indicated that proinsulin C‐peptide shows specific binding to cell membrane binding sites and may exert biological effects when administered to patients with Type 1 diabetes mellitus. This study was undertaken to determine if combined treatment with C‐peptide and insulin might reduce the level of microalbuminuria in patients with Type 1 diabetes and incipient nephropathy. Methods Twenty‐one normotensive patients with microalbuminuria were studied for 6 months in a double‐blind, randomized, cross‐over design. The patients received s.c. injections of either human C‐peptide (600 nmol/24 h) or placebo plus their regular insulin regimen for 3 months. Results Glycaemic control improved slightly during the study and to a similar extent in both treatment groups. Blood pressure was unaltered throughout the study. During the C‐peptide treatment period, urinary albumin excretion decreased progressively on average from 58 μg/min (basal) to 34 μg/min (3 months, P < 0.01) and it tended to increase, but not significantly so, during the placebo period. The difference between the two treatment periods was statistically significant (P < 0.01). In the 12 patients with signs of autonomic neuropathy prior to the study, respiratory heart rate variability increased by 21 ± 9% (P < 0.05) during treatment with C‐peptide but was unaltered during placebo. Thermal thresholds were significantly improved during C‐peptide treatment in comparison to placebo (n = 6, P < 0.05). Conclusion These results indicate that combined treatment with C‐peptide and insulin for 3 months may improve renal function by diminishing urinary albumin excretion and ameliorate autonomic and sensory nerve dysfunction in patients with Type 1 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Method for the Determination of Glomerular Filtration Rate
Bröchner-Mortensen, J. (1972) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517209084290 · Cited by 886
Method for quantitative estimation of thermal thresholds in patients.
Fruhstorfer, H., Lindblom, U., & Schmidt, W. C. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.11.1071 · Cited by 781
Johnson, R. N., Metcalf, P. A., & Baker, J. R. (1983) · Clinica Chimica Acta · doi:10.1016/0009-8981(83)90078-5 · Cited by 763
Insulin Biosynthesis: Evidence for a Precursor
Steiner, D. F., Cunningham, D., Spigelman, L., & Aten, B. (1967) · Science · doi:10.1126/science.157.3789.697 · Cited by 712
Mathiesen, E. R., Hommel, E., Giese, J., & Parving, H. H. (1991) · BMJ · doi:10.1136/bmj.303.6794.81 · Cited by 464
Goldberg, J. M., & Lindblom, U. (1979) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.9.793 · Cited by 406
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre, M., Chatellier, G., Leblanc, H., Guyene, T. T., Menard, J., & Passa, P. (1988) · BMJ · doi:10.1136/bmj.297.6656.1092 · Cited by 373
Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide
Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E., & Williamson, J. R. (1997) · Science · doi:10.1126/science.277.5325.563 · Cited by 341
Specific binding of proinsulin C-peptide to human cell membranes
Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, P.-Å., Ståhl, S., Ekberg, K., Johansson, B.-L., Uhlén, S., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13318 · Cited by 328
Self-citationJeppsson, J. O., Jerntorp, P., Sundkvist, G., Englund, H., & Nylund, V (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.10.1867 · Cited by 299
Respiratory influence on heart rate in diabetes mellitus.
Sundkvist, G., Almer, L. O., & Lilja, B. (1979) · BMJ · doi:10.1136/bmj.1.6168.924 · Cited by 245
Johansson, B. L., Sj�berg, S., & Wahren, J. (1992) · Diabetologia · doi:10.1007/bf00402543 · Cited by 196
Self-citationC-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y
Ohtomo, Y., Aperia, A. C., SAHLGREN, B., Johansson, B., & Wahren, J. (1996) · Diabetologia · doi:10.1007/bf00403963 · Cited by 154
Self-citationJohansson, B., Linde, B., & Wahren, J. (1992) · Diabetologia · doi:10.1007/bf00401369 · Cited by 139
Self-citationC-peptide improves autonomic nerve function in IDDM patients
Johansson, B., Borg, K., Fernqvist‐Forbes, E., Odergren, T., Remahl, S., & Wahren, J. (1996) · Diabetologia · doi:10.1007/bf00418540 · Cited by 132
Self-citationForst, T. M., Kunt, T., Pohlmann, T., Goitom, K., Engelbach, M., Beyer, J., & Pfützner, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2147 · Cited by 126
Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus
Sundkvist, G., Lilja, B., & Alm�r, L. O. (1980) · Diabetologia · doi:10.1007/bf00281822 · Cited by 118
Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat
Greene, D. A., Yagihashi, S., Lattimer, S. A., & Sima, A. A. F. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.4.e534 · Cited by 110
Arnqvist, H. J., Olsson, P. O., & von Schenck, H. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.1.93 · Cited by 86
Hallab, M., Gallois, Y., Châtellier, G., Rohmer, V., Fressinaud, P., & Marre, M. (1993) · BMJ · doi:10.1136/bmj.306.6871.175 · Cited by 78
Characterization of the Early Stages of Diabetic Retinopathy by Vitreous Fluorophotometry
Cunha-Vaz, J. G., Gray, J. R., Zeimer, R. C., et al. (1985) · Diabetes · doi:10.2337/diab.34.1.53 · Cited by 69
Autonomic nerve function tests. Reference values in healthy subjects
Bergstrom, B., Lilja, B., Rosberg, K., & Sundkvist, G. (1986) · Clinical Physiology · doi:10.1111/j.1475-097x.1986.tb00785.x · Cited by 64
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“During this process, the pancreatic -cells within the islets of Langerhans are destroyed, resulting in individuals with this condition relying essentially on exogenous insulin administration for survival, although a subgroup has significant residual C-peptide production (295).”
BackgroundInfluentialA practical review of C-peptide testing in diabetes
Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0265-4 · Cited by 773
“Some preliminary randomized controlled trials demonstrate that giving subcutaneous c-peptide alongside insulin to individuals with T1DM may ameliorate microvascular complications, such as albuminuria and autonomic nerve dysfunction [62, 63].”
BackgroundPalmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Total Pancreatectomy and Islet Autotransplantation for Chronic Pancreatitis
Sutherland, D. E. R., Radosevich, D. M., Bellin, M. D., Hering, B. J., Beilman, G. J., Dunn, T. B., Chinnakotla, S., Vickers, S. M., Bland, B., Balamurugan, A. N., et al. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.12.040 · Cited by 461
Vallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376
Metadata
- Authors
- Johansson, B. ‐., Borg, K., Fernqvist‐Forbes, E., Kernell, A., Odergren, T., & Wahren, J.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 17
- Issue
- 3
- Pages
- 181-189
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2147179036
- Cited by
- 257
- References
- 22
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.